Showing results (391-400 of 531) with videos related to
Sort By:
Pageof 54
Journal of Neural Transmission (Vienna, Austria : 1996)|May 16, 2000
Altered redox state of platelet coenzyme Q10 in Parkinson's diseaseM E Götz, A Gerstner, R Harth, et al.European Archives of Psychiatry and Clinical Neuroscience|July 31, 1998
Susceptibility for schizophrenia is not influenced by a functional insertion/deletion variant in the promoter of the serotonin transporter geneG Stöber, S Jatzke, A Heils, et al.Alcohol and Alcoholism (Oxford, Oxfordshire)|January 1, 1997
Increased concentrations of manganese superoxide dismutase in serum of alcohol-dependent patientsJ Thome, P Foley, W Gsell, et al.Schizophrenia Research|October 12, 2001
Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychosesN Durany, T Michel, R Zöchling, et al.Brain Research|July 17, 1999
Characterization and regional distribution of nitric oxide synthase in the human brain during normal ageingD Blum-Degen, T Heinemann, J Lan, et al.Experimental Neurology|November 26, 2003
The dopamine receptor agonist lisuride attenuates iron-mediated dopaminergic neurodegenerationK L Double, G M Halliday, J Henderson, et al.Journal of Neural Transmission. General Section|January 1, 1994
Organization of the human serotonin transporter geneK P Lesch, U Balling, J Gross, et al.Psychiatry Research|January 30, 1999
Peripheral-type benzodiazepine receptors in diagnostic subtypes of schizophrenic patientsN Wodarz, C Rothenhöfer, R Fischer, et al.Advances in Neurology|January 1, 1987
Localization of MAO-A and MAO-B in human brain: a step in understanding the therapeutic action of L-deprenylP Riederer, C Konradi, V Schay, et al.Journal of Neural Transmission. Supplementum|April 24, 2007
Antioxidant capacity in postmortem brain tissues of Parkinson's and Alzheimer's diseasesE Sofic, A Sapcanin, I Tahirovic, et al.Pageof 54